Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Immunol. 2011 Feb 9;186(5):3047–3057. doi: 10.4049/jimmunol.1002695

Table I. Summary of multi-platform gene-expression data.

A) Splenic CD4+ T cells and CD19+ B cells were profiled on Affymetrix, Agilent, Nimbelgen and Illumina whole-genome microarrays. Resulting gene-expression data from each platform were analyzed to yield the percentage of expressed probes, percentage of false-positives (defined as a probe being expressed on one platform, but not the other three), percentage of false-negatives (defined as the absence of a probe's expression in one platform but present in the other three) and overall concordance (defined as the overall percentage of probes whose expression or absence is in agreement with the majority of platforms). B) The overall expression of the genome in T and B cells was calculated based on the number of genes registering as significantly expressed for each platform with concordance being defined as a given gene's expression or absence in 2, 3 or 4 out of 4 platforms (rows).

Table IA
Sample Expressed genes (%) False-positives (%) False-negatives (%) Overall Concordance (%)
Affymetrix CD19 51 8 2 84
Affymetrix CD4 50 8 2 84
Agilent CD19 43 4 7 92
Agilent CD4 43 4 7 92
Illumina CD19 47 9 8 84
Illumina CD4 47 10 8 83
Nimblegen CD19 46 5 4 89
Nimblegen CD4 46 4 4 89
Table IB
Concordant Chips Expressed in CD4 (%) Expressed in CD19 (%)
2 of 4 49.74 49.67
3 of 4 43.26 43.35
4 of 4 32.41 32.06